Scrip ID
MANINDS
Nature of Disclosure: Regulatory intimation of upcoming board meeting to consider and approve quarterly financial results.
Key Details:
- A meeting of the Board of Directors is scheduled to be held on Thursday, November 12, 2026
- The meeting will consider and approve the Unaudited Financial Results for:
- Quarter ended September 30, 2026
- Half year ended September 30, 2026
- Both Standalone and Consolidated financial results will be considered
- The results will include the Limited Review Report thereon
Regulatory Context:
- Disclosure made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015
- Addressed to both BSE Limited and National Stock Exchange of India Ltd
Financial Impact: Financial results not yet disclosed or quantified in this intimation. Actual financial figures will be announced post-board meeting approval.
Company Representative: Rahul Rawat, Company Secretary (M. No.: A27891) signed the disclosure.